New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Samsung Asset Management›244580

244580

Samsung KODEX Biotech ETF

Passive ETF Equity

Not rated

The 244580 Exchange Traded Fund (ETF) is provided by Samsung Asset Management. It is built to track an index: FnGuide Inc Bio Index. The 244580 ETF provides physical exposure, so by buying it you actually own parts of all the 50 underlying holdings. This share class generates a stream of income by distributing dividends.

₩7,400

+₩480 (+6.94%) today

12:00 AM 07/31/26 Closed

1D price range

₩7,025₩7,495

52W price range

₩6,943.51₩14,183.9

YTD Perf.

-44.49%

YTD Flows

Annualized volatility

Fund AuM

€108M

Share class AuM

€108M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7244580007

TER

0.45%

Inception date

5/12/2016

Issuer

Samsung Asset Management

Benchmark

FnGuide Inc Bio Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

No content available for this fund

API

PerformanceDec 30, 2025 - Jul 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

93.93%

Industrials

2.28%

Non-Energy Materials

1.95%

Consumer Non-Cyclicals

1.50%

Unavailable

0.33%

Latest 244580 news

No content available for this fund

FAQ about 244580

244580 is a Passive ETF. This ETF provides exposure to Equally Weighted South Korean Biotechnology Equities.

244580 tracks the FnGuide Inc Bio Index - KRW, through a full replication replication method.

244580 carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.

244580 was introduced to the market on May 12, 2016. It trades on South Korea

Samsung KODEX Biotech ETF, 244580, is provided by Samsung Asset Management. Learn more about Samsung Asset Management here.

244580 oversees €108M in assets as of July 30, 2026.

244580 follows a distributing dividend policy, meaning it pays out income to investors.

As of June 30, 2026, 244580 has significant geographic allocations in Republic of Korea.

As of June 30, 2026, 244580 focuses largely on Healthcare, Industrials and Non-Energy Materials.

As of June 30, 2026, 244580 holds 50 positions in its portfolio, with 34.80% of assets concentrated in its top 15 holdings.

As of June 30, 2026, 244580 top three holdings include SEERS Co., Ltd., PharmaResearch Co., Ltd. and OliX Pharmaceuticals, Inc..

The base currency of 244580 is KRW.

Top 10 holdings

Data as of 06/30/26

SEERS Co., Ltd.

2.80%

PharmaResearch Co., Ltd.

2.62%

OliX Pharmaceuticals, Inc.

2.60%

HANALL BIOPHARMA Co., Ltd.

2.46%

LigaChem Biosciences, Inc.

2.31%

HLB Co., Ltd.

2.28%

SAMSUNG BIOLOGICS Co., Ltd.

2.23%

ST Pharm Co., Ltd.

2.23%

L&C BIO Co., Ltd.

2.23%

Hugel, Inc.

2.23%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Samsung KODEX Biotech ETF

FAQ about 244580

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US